dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Pazopanib in Molecularly Selected Patients With Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
- Status
- COMPLETED
- Phase
- NA
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
- Status
- COMPLETED
- Phase
- PHASE2
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
- Status
- COMPLETED
- Phase
- PHASE4
Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- Status
- RECRUITING
- Phase
- N/A
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
- Status
- COMPLETED
- Phase
- N/A
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
- Status
- TERMINATED
- Phase
- PHASE3
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)
- Status
- COMPLETED
- Phase
- N/A
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2